What one share of Dr. Reddy’s Laboratories Limited holds
Established in 1984, we are an integrated global pharmaceutical company committed to accelerating access to affordable and innovative medicines. Our reportable operating segments are as follows:
Dr. Reddy’s Laboratories Limited’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $4.57 |
|---|---|
| Profit | $0.58 |
| Capex (buildings and equipment) | $0.32 |
| Free cash flow | $0.45 |
| Dividends | $0.09 |
| Cash and investments | $0.20 |
| Debt | $0.23 |
| Book value | $4.83 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $2.77 | $0.36 | $0.21 | $0.52 | $0.06 | $2.27 |
| 2017 | $2.52 | $0.22 | $0.22 | $0.17 | $0.06 | $2.24 |
| 2018 | $2.65 | $0.18 | $0.17 | $0.16 | $0.06 | $2.34 |
| 2019 | $2.65 | $0.32 | $0.12 | $0.38 | $0.06 | $2.44 |
| 2020 | $2.97 | $0.33 | $0.08 | $0.42 | $0.06 | $2.48 |
| 2021 | $3.07 | $0.28 | $0.16 | $0.42 | $0.07 | $2.85 |
| 2022 | $3.46 | $0.38 | $0.24 | $0.22 | $0.07 | $3.03 |
| 2023 | $3.68 | $0.68 | $0.17 | $0.71 | $0.07 | $3.39 |
| 2024 | $4.05 | $0.81 | $0.24 | $0.42 | $0.10 | $4.05 |
| 2025 | $4.62 | $0.80 | $0.39 | $0.27 | $0.09 | $4.69 |
| 2026 | $4.57 | $0.58 | $0.32 | $0.45 | $0.09 | $4.83 |
Common questions about Dr. Reddy’s Laboratories Limited
How much does one share of Dr. Reddy’s Laboratories Limited earn?
Over its latest fiscal year, each share of Dr. Reddy’s Laboratories Limited earned $0.58 of profit on $4.57 of sales, keeping about 13¢ of every $1 (profit margin).
Does Dr. Reddy’s Laboratories Limited pay a dividend?
Yes. Dr. Reddy’s Laboratories Limited paid $0.09 per share in dividends over its latest fiscal year, and it paid a dividend in every year from 2016 to 2026 in StockSlicer’s data. That’s about 16¢ of each $1 of profit (payout ratio).
What is Dr. Reddy’s Laboratories Limited’s book value per share?
Dr. Reddy’s Laboratories Limited’s book value is $4.83 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of March 31, 2026.
How much cash and debt does each share of Dr. Reddy’s Laboratories Limited have?
Each share of Dr. Reddy’s Laboratories Limited has $0.20 of cash and investments and $0.23 of debt, as of March 31, 2026.
What is Dr. Reddy’s Laboratories Limited’s free cash flow per share?
$0.45 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
How has Dr. Reddy’s Laboratories Limited’s profit per share changed over time?
Profit per share went from $0.36 in 2016 to $0.58 in 2026, growing about 5.0% a year (adjusted for stock splits).
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.